Cancer MB&B 323

Instructor: Alexia Belperron

Brief Description: an introduction to cancer with a focus on genetics, biochemistry, immunity, infection agents, and the associated challenges to prevention and treatment.

Format: The course will be conducted as a seminar, interspersing the presentation of material by the instructor with frequent opportunities for discussion. There will also be in depth discussion on research papers throughout the semester. The course will meet twice weekly.

Learning objectives: The main purpose of the course will be the development of an understanding of the biology of cancer: including gaining an understanding of normal cell cycle biology and the genetic changes involved in converting a normal cell into a cancerous cell, the roles carcinogens, inherited genetic mutations, and infectious diseases play in the development of cancer, how the immune system responds, and how it can be harnessed for treatment, the biochemistry of chemotherapy, and the biology underlying preventative measures. Throughout the course, the emphasis will be on understanding the core biological principles and how an understanding of these principles is essential to understanding how cancer develops, how it can be treated, and how we can try to prevent its development. The class will focus on a subset of cancers as examples, including leukemias, skin cancer, and those linked to infections.

Grading will be based on the performances on an in-class 80-minute midterm given in week 8 (33%), 3 quizzes given during weeks 4,7 and 13 (7% each), a group presentation in the second half of the semester (20%), Journal Club presentation (16%), and overall class participation (10%).

Group Presentation: Four groups, with ~5 students each, will prepare 40-minute presentations on a specific cancer (colon, breast, prostate, or lung). They will be asked to cover topics including, development of disease, risk factors and treatments and offer suggestions for future uses or research on the topic and how that would benefit the cancer field.Afterwards there will be a question and answer period during which other students and the instructor will ask questions of the presenters. The purpose is to get students thinking in-depth about how they might apply the knowledge they have gained in the class to understanding different types of cancer.

Journal Club: Two to three students will work together to present and explain the data reported in the articles we will be reading throughout the semester. Students will give an overview of the paper to the class, and then explain the experiments that were done in each of the figures.

Texts

Cancer: A Beginners Guide, Paul Scotting. London: Oneworld Publications, 2010. ISBN 10: 1851687556.

Supplemental Materials

Understanding Leukemias Lymphomas and Myelomas, Tariq Mughal, John, Goldman, and Sabena Mughal. London: Taylor & Francis Group, 2006. ISBN1841844098.

Cancer Cell Metabolism and Cancer Treatment, AurelLupulescu. Australia: Harwood Academic Publishers, 2010. ISBN 905702604X.

Primary articles from Nature, and other peer-reviewed journals.

Online Sources including those of the NCI, the ACS, and Cancerquest.

Taming the dragon: genomic biomarkers to individualize the treatment of cancer. Nature Medicine 17, 304-312, 2011.

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.Nature Medicine 17, 304-312, 2011.

Timeline: a decade of advances in immunotherapy.Nature Medicine 17,296, 2011.

Targeting the missing links for cancer therapy. Nature Medicine 17,283-284, 2011.

The Genomic Landscapes of Human Breast and Colorectal Cancers. Science Vol. 308, 1108-1113, 2007 (In this paper, try to understand the big picture, not the technical details)

.Prophylactic human papillomavirus vaccines.JCI Vol 116, 1167-73, 2006

Using the immune response to attack tumors

Helicobacter pylorivacuolatingcytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. PNAS September 20, 2011 vol. 108 no. 38 16032-16037

nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development, Cell, Volume 145, Issue 3, 29 April 2011, Pages 435-446

Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression, Cancer Cell, Volume 19, Issue 6, 14 June 2011, Pages 715-727

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine, 17, 854-859, 2011.

Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cellsto DNA damage, PNAS vol 105, no. 44, pages 16985-16963, 2008.

Jan 31**:Session 1 Introduction to cancer

Goals: Students will learn about the sizable burden cancer places on the world’s population and get a preview about the complexities of the biology, evasive strategies, and adaptive evolution that different cancers exhibit.

Reading: Cancer: Beg. Guide-Introduction and Chapter 1

Feb 2,7:Sessions 2-3* Genes: From DNA damage to cancer

Goals: The cell cycle will be reviewed, and students will learn how DNA damage leads todisregulation of the cell cycle and subsequent development of tumors. They will learn about the difference between a tumor suppressor and an oncogene.

Reading:

Cancer: Beg. Guide-Chapters 2-5, Appendices 1-2

(online cell cycle game)

(you should complete the 1) cell structure, 2) mutation, and 3) oncogene flows)

* Tues, 2/7: Journal Club Paper discussion: Prof Belperron will lead

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer, Nature Medicine, Vol. 11(1) pages 63-70, 2005.

Feb 9,14:Sessions4-5* Carcinogens

Goals: Students will learn about how carcinogens lead to the development of cancers with a focus on skin cancer.

Reading: Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.Nature Medicine 17, 320-29, 2011.

Cancer: Beg. Guide-Chapters 6-7.

(complete the quiz)

*Tues, 2/14 Journal Club Paper discussion: 1st group student leaders

Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development, Cell, Volume 145, Issue 3, 29 April 2011, Pages 435-446

Feb 16:Session 6Quiz and Genetic predisposition/inherited cancer risks

Goals: Students will learn about the role hereditary mutations play in the risk of developing cancer

Reading: Cancer: Beg. Guide-Chapters 9-11, Appendix 4

Feb 21:Session 7* Genetic Analysis of tumors

Goals: Students will learn about different gene expression profiles of cancers and how biomarkers can be used to diagnose, determine treatment, anddetermine the evolutionary origins of the cancer within the body.

* Tues. Journal Club Paper discussion: 2nd group student leaders

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer.NEJM Vol 351, 2817-26, 2004

Reading :The Genomic Landscapes of Human Breast and Colorectal Cancers. Science Vol. 308, 1108-1113, 2007

Taming the dragon: genomic biomarkers to individualize the treatment of cancer. Nature Medicine 304-312, 2011

Feb 23,28Sessions 8-9* Infectious diseases and their role in cancer

Goals: Students will learn about the role different infectious agents play in the development of cancer

Reading: Cancer: Beg. Guide-Chapter 8

.Prophylactic human papillomavirus vaccines.JCI Vol 116, 1167-73, 2006

*Tues.,2/28 Journal Club Paper discussion:3rd group student leaders

Helicobacter pylorivacuolatingcytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. PNAS September 20, 2011 vol. 108 no. 38 16032-16037

.

March 1,6:Sessions 10-11*Biology of immune responsesand how the immune system responds to tumors:

Goals: Students will learn the basics of immunology needed to understand the role the immune system plays in surveillance and tumor control

Reading: Course Packet: How the Immune System works, Chapters 1,4,5, and 11

Chapter 53-Cancer and the Cellular Immune Response (Online source)

*Tues., 3/6 Journal Club Paper discussion: 4th group student leaders

Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression, Cancer Cell, Volume 19, Issue 6, 14 June 2011, Pages 715-727

March 8:Session 12Quizand cont. of immune responses to tumors:

Reading: Using the immune response to attack tumors

March 27:Session 13Cancers of the immune system

Goals: Students will learn about the development of leukemias and lymphomas

Reading: Understanding Leukemias Lymphomas and Myelomas, Tariq Mughal, John, Goldman, and Sabena Mughal. London: Taylor & Francis Group, 2006. ISBN1841844098-Chap. 3 pgs 27-46.

March 29:Sessions 14Treatment tactics: Treatments-past and present

Goals: Students will get an overviewabout the different approaches used to treat cancer and will be asked to think about the ways they would choose to target the disease based on what they have learned about its biology. This discussion will serve as a review for the midterm.

April 3:Session 15In-class midterm

April 5,10:Session 16-17*Treatment tactics: Chemotherapy

Goals: Students will learn the basic biochemistry of several chemotherapeutic drugs with broad usage in different cancers and will learn about the cellular pathways the drugs are designed to inhibit.

Reading: Cancer: Beg. Guide-Chapter 12

* Tues, 4/10 Journal Club Paper Discussion:5th group student leaders

Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cellsto DNA damage, PNAS vol 105, no. 44, pages 16985-16963, 2008.

April 12:Session 18Treatment tactics: Chemotherapy cont.

Goals: Students will learn about the biochemistry of action of cancer-specific chemotherapies and compare and contrast them to more broad-based cytotoxic drugs.

Reading: Targeting the missing links for cancer therapy. Nature Medicine 17,283-284, 2011.

April 17:Session 19*Treatment tactics: Harnessing the Immune system

Goals: students will learn about new approaches to activate the immune system to destroy cancers.

*Tues., Journal Club Paper discussion: 6th group student leaders

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine, 17, 854-859, 2011.

Readings:http://.html: Timeline: a decade of advances in immunotherapy.Nature Medicine 17,296, 2011.

April 19:Session 20Treatment tactics: Harnessing the Immune system cont. and Student Group 1 presentation

Goals: Abbreviated lecture on immune-based cancer treatment

Group 1 presentation

April 24:Session 21Tactics for prevention: Avoiding carcinogens and Student StudentGroup 2 presentation

Goals: Abbreviated lecture on the biological basis for the success of avoiding carcinogens (smoke, sun, chemical….) in the prevention of cancer.

Reading: Cancer: Beg. Guide-Chapter 13

Group 2 presentation

April 26:Sessions 22Tactics for prevention: Avoiding carcinogens cont. and Student Group 3 presentation

Goals: Abbreviated lecture #2 on the biological basis for the success of avoiding carcinogens (smoke, sun, chemical….) in the prevention of cancer.

Group 3presentation

May 1:Session 23Tactics for prevention: Lifestyle changes

Goals: Students will learn thebasic biology of the recommendations for suggested dietary and life style changes that are purported to reduce the likelihood of cancerdevelopment

*Journal Club Paper discussion: 7th group student leaders

Selective Depletion of Mutant p53 by Cancer ChemopreventiveIsothiocyanates and Their Structure−Activity Relationships.Journal of Medicinal Chemistry201154 (3), 809-816

Reading:Cancer Cell Metabolism and Cancer Treatment, AurelLupulescu. Australia: Harwood Academic Publishers, 2010. ISBN 905702604X. Chap. 7, pgs, 173-208.

May 3:Session 24Quizand Latest findings and research

Goals: This last lecture and discussion will be devoted to newly published cancer research findings.

*Paper discussion: Research article to be determined based on latest findings.

May 8:Session 26 Summary and Student Group 4 presentation

Goals: Semester Summary and

Group 4 presentation